{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-035055","form_type":"8-K","ticker":"BBIO","cik":"0001743881","company_name":"BridgeBio Pharma, Inc.","filed_at":"2026-08-31T19:54:51+00:00","discovered_at":"2026-08-31T19:56:02.660120+00:00","generated_at":"2026-08-31T19:56:10.909515+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BridgeBio announces voluntary U.S. government agreement to expand Medicaid access, avoid pricing mandates","bullets":["Voluntary agreement with U.S. government expands Medicaid access to Attruby via GENEROUS Model; specific terms confidential.","BridgeBio expects no future pricing mandates; pricing commitments exclude medicines approved exclusively for orphan indications.","CEO Neil Kumar joined President Trump at White House to announce deal; no impact on ForgingBridges copay program ($0/mo for qualifying patients).","Three drugs under FDA review: BBP-418 (PDUFA Nov 27, 2026), encaleret (PDUFA May 7, 2027), infigratinib for achondroplasia."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-035055","json":"https://secwatch.observer/filing/0001140361-26-035055.json","markdown":"https://secwatch.observer/filing/0001140361-26-035055.md","text":"https://secwatch.observer/filing/0001140361-26-035055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1743881/000114036126035055/0001140361-26-035055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1743881/000114036126035055/ef20081330_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-31T19:56:10.909515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}